MOODY'S CORP (MCO)       317.89  +3.37 (+1.07%)

317.89  +3.37 (+1.07%)

US6153691059 - Common Stock - After market: 317.89 0 (0%)


Fundamental Rating

3

Taking everything into account, MCO scores 3 out of 10 in our fundamental rating. MCO was compared to 202 industry peers in the Capital Markets industry. While MCO is still in line with the averages on profitability rating, there are some concerns on its financial health. While showing a medium growth rate, MCO is valued expensive at the moment.




Profitability

Profitability Rating

4

MCO has a Return On Assets of 9.58%. This is better than the industry average of 4.11%.
MCO has a Return On Equity of 54.55%. This is amongst the best returns in the industry. The industry average is 11.60%. MCO outperforms 94% of its industry peers.

MCO's Profit Margin of 25.13% is in line with the rest of the industry. The industry average Profit Margin is 19.63%.
MCO has a very weak Piotroski-F score of 2.00. This is an indication of health and profitability issues for MCO.
VS Industry

ROA (9.58%) VS Industry: 76% outperformed.

0.03
49.12

ROE (54.55%) VS Industry: 94% outperformed.

0.18
291.37

Profit Margin (25.13%) VS Industry: 60% outperformed.

0.30
84,632.11

Valuation

Valuation Rating

0

With a Price/Earnings Ratio of 42.78, MCO can be considered very expensive at the moment.
Compared to an average industry Price/Earning Ratio of 11.67, MCO is valued more expensive than its industry peers. On top of this 93% of the companies listed in the same industry are cheaper than MCO!
With a Forward Price/Earnings Ratio of 33.64, MCO is valued very expensively.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
When comparing the current price to the book value of MCO, we can conclude it is valued rather expensively. It is trading at 23.12 times its book value.
Compared to an average industry price book ratio of 1.22, MCO is valued more expensive than its industry peers. 99% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Earnings (42.78) VS Industry: 7% outperformed.

247.50
0.92

Price/Book (23.12) VS Industry: 1% outperformed.

67.22
0.15

Growth

Growth Rating

5

The Earnings Per Share is expected to grow by 15.56% on average over the next 5 years. This is quite good.
The EPS growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Revenue growth is accelerating: in the next 5 years the growth will be better than in the last years.
The Earnings Per Share has been growing slightly by 7.62% on average over the past 5 years.

The Revenue has been growing slightly by 5.40% on average over the past 5 years.
The Revenue is expected to grow by 8.62% on average over the next 5 years.
The earnings per share for MCO have decreased strongly by -36.93% in the last year.
MCO shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -12.06%.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS7.62% 0.08% -36.93% 11.52% 16% 17.14% 15.56%
Revenue5.4% 4.23% -12.06% 6.76% 8.62% 9.49% 8.62%

Health

Health Rating

2

MCO has a Current Ratio of 1.72. This is a normal value and indicates that MCO is financially healthy and should not expect problems in meeting its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.28.
MCO has a Quick Ratio of 1.72. This is a normal value and indicates that MCO is financially healthy and should not expect problems in meeting its short term obligations.

The Quick Ratio is in line with the industry averages, which is at 1.28.
MCO has one of the worst Debt to Equity ratios in its industry. 92% of its industry peers require less debt for financing their operations.
The Piotroski-F score of MCO is 2.00. This is a very weak score and indicates problems in health and profitability for MCO.
VS Industry

Debt/Equity (2.93) VS Industry: 8% outperformed.

8.26
0.00

Quick Ratio (1.72) VS Industry: 59% outperformed.

0.01
5,803.88

Current Ratio (1.72) VS Industry: 58% outperformed.

0.01
5,803.88

Dividend

Dividend Rating

4

The dividend of MCO is nicely growing with an annual growth rate of 11.87%!
MCO's earnings are growing more than its dividend. This makes the dividend growth sustainable.
MCO has been paying a dividend for at least 10 years, so it has a reliable track record.

MCO has a yearly dividend return of 0.95%, which is pretty low.
Compared to an average industry Dividend Yield of 4.95, MCO's dividend is way lower than its industry peers. On top of this 92% of the companies listed in the same industry pay a better dividend than MCO!
With a Dividend Yield of 0.95, MCO pays less dividend than the S&P500 average, which is at 2.42.
VS Industry

Dividend Yield (0.95%) VS Industry: 8% outperformed.

0.02
168.27

MOODY'S CORP317.89

NYSE:MCO (2/7/2023, 7:04:00 PM)+3.37 (+1.07%)

After market: 317.89 0 (0%)

Chartmill FA Rating
GICS Sector Financials
GICS IndustryGroup Diversified Financials
GICS Industry Capital Markets
Earnings (Last) 01-31 2023-01-31/amc Earnings (Next) 05-01 2023-05-01/amc
Inst Owners 91.65% Inst Owner Change -52.72%
Ins Owners 0.13% Ins Owner Change 0.14%
Market Cap 58.24B Analysts 75.83
Price Target 301.6 (-5.12%)

Dividend
Industry RankSector Rank
Dividend Yield 0.95%
Dividend Growth(5Y) 11.87% DP 0%
Div Incr Years 13 Div Non Decr Years 17
Ex-Date N/A

Surprises & Revisions
EPS beat(2) N/A Avg EPS beat(2) -10.91%
Min EPS beat(2) -10.91% Max EPS beat(2) -10.91%
EPS beat(4) N/A Avg EPS beat(4) -5.62%
Min EPS beat(4) -10.91% Max EPS beat(4) -1.42%
Revenue beat(2) 1 Avg Revenue beat(2) -2.53%
Min Revenue beat(2) -6.8% Max Revenue beat(2) 1.74%
Revenue beat(4) 2 Avg Revenue beat(4) -2.24%
Min Revenue beat(4) -6.8% Max Revenue beat(4) 1.74%
PT rev (1m) 2.01% PT rev (3m) 4.95%
EPS NQ rev (1m) 0.56% EPS NQ rev (3m) -4.87%
EPS NY rev (1m) 0% EPS NY rev (3m) -13.25%
Revenue NQ rev (1m) -0.42% Revenue NQ rev (3m) -1.16%
Revenue NY rev (1m) 0% Revenue NY rev (3m) -1.61%

Valuation
Industry RankSector Rank
PE 42.78
Fwd PE 33.64
P/S 10.65
P/FCF N/A
P/OCF N/A
P/B 23.12
P/tB N/A
EV/EBITDA N/A
EPS(TTM) 7.43 EY 2.34%
EPS(NY) 9.45 Fwd EY 2.97%
FCF(TTM) N/A FCFY N/A
OCF(TTM) N/A OCFY N/A
SpS 29.85 BVpS 13.75
TBVpS -30.19 PEG (NY) 3.71
PEG (5Y) 5.61

Profitability
Industry RankSector Rank
ROA 9.58%
ROE 54.55%
ROIC 13.21%
ROICexc 15.64%
ROICexgc 76.57%
OM 36.52%
PM 25.13%
GM 70.5%
ROICexgc(3y) 125.03% ROICexcg growth 3Y -17.55%
ROICexcg growth 5Y -45.46% ROICexc(3y) 21.14%
ROICexc growth 3Y -15.14% ROICexc growth 5Y -10.12%
OM growth 3Y -5.28% OM growth 5Y -3.59%
PM growth 3Y -5.15% PM growth 5Y 1.09%
GM growth 3Y -0.36% GM growth 5Y -0.16%
F-Score 2 Asset Turnover 0.38

Health
Industry RankSector Rank
Debt/Equity 2.93
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Profit Quality N/A
Current Ratio 1.72
Quick Ratio 1.72
Altman-Z N/A
F-Score 2 WACC N/A
ROIC/WACC N/A Cap/Depr(3y) N/A
Cap/Depr(5y) N/A Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -36.93% EPS 3Y 0.08%
EPS 5Y 7.62% EPS growth Q2Q -41.23%
EPS Next Y 11.52% EPS Next 2Y 16%
EPS Next 3Y 17.14% EPS Next 5Y 15.56%
Revenue growth 1Y -12.06% Revenue growth 3Y 4.23%
Revenue growth 5Y 5.4% Revenue growth Q2Q -16.18%
Revenue Next Year 6.76% Revenue Next 2Y 8.62%
Revenue Next 3Y 9.49% Revenue Next 5Y 8.62%
EBIT growth 1Y -29.78% EBIT growth 3Y -1.27%
EBIT growth 5Y 1.61% EBIT Next Year 24.24%
EBIT Next 3Y 17.81% EBIT Next 5Y 14.56%
FCF growth 1Y N/A FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y N/A
OCF growth 3Y N/A OCF growth 5Y N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA